Please login or register first to view this content.
Drug News
Phase 3 Study of Investigative Glioblastoma Tx Halted
Gattex Approved for Pediatrics With Short Bowel Syndrome
Updated NLA Guidance Identifies Patients in Which PCSK9i Use Provides Reasonable Value
Dabigatran Does Not Beat Aspirin for Preventing Recurrent Stroke
North Carolina Sues Electronic Cigarette Maker JUUL
Smartphone App Could Help Diagnose Ear Infections
Cannabis Legalization Not Tied to Higher Health Care Utilization
First Anticoagulant Approved to Treat Symptomatic VTE in Pediatric Patients
Benzodiazepine Use in Early Pregnancy Linked to Spontaneous Abortion
Mirvetuximab Soravtansine Data Lacking for FDA’s Accelerated Approval in Ovarian CA
Habitual Glucosamine Use Linked to Reduced Risk for CVD Events
Chemotherapy-Free Combo Therapy Approved for Previously Untreated CLL
Thyroid Hormones Not Endorsed for Subclinical Hypothyroidism
Two-Thirds of Sunscreens Fail Safety Tests
FDA: Tattoo Inks Recalled Due to Bacterial Contamination
Bavencio Plus Inlyta Approved as First-Line Tx for Advanced Renal Cell Carcinoma
Abrocitinib Looks Promising in Phase 3 Atopic Dermatitis Trial
FDA Panel Backs Pexidartinib for Rare Tumor, Votes Against Quizartinib for FLT3-ITD AML
